CANSF Willow Biosciences Inc.

Willow Biosciences, Inc. is a biotechnology company. It develops synthetic biology solutions for opioid biosynthesis. The firm offers biosynthetic production systems for plant-derived active pharmaceutical ingredients (API) and intermediates. The company was founded on April 12, 2019 and is headquartered in Calgary, Canada.

Note: This is not a U.S. company, but they cross-list their shares on the U.S. over-the-counter market - see the related symbol CT:WLLW.

$1.05    OTCQX
As of 03/03/2021     OTCMarkets


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Materials
Drug Manufacturers—Specialty &
Canada

01/12/2004
114,022,319
58,250
$119,723,435
0.00%



Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-11.22
68.22
0.00
-611.38%
-939,668.26%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy